Navigation Links
Brucella abortus S19 genome sequenced; points toward virulence genes
Date:6/5/2008

Blacksburg, Va. Researchers at the Virginia Bioinformatics Institute at Virginia Tech and the National Animal Disease Center in Ames, Iowa, and collaborators at 454 Life Sciences of Branford, Conn., have sequenced the genome of Brucella abortus strain S19. Strain S19 is a naturally occurring strain of B. abortus that does not cause disease and was discovered by Dr. John Buck in 1923. It has been used for more than six decades as vaccine that protects cattle against brucellosis, an infectious disease caused by other strains of B. abortus that leads to reproductive failure in livestock.

Scientists have long wanted to know what genetic features make strain S19 suitable for use as a vaccine in cattle because it may hold the secret as to why other Brucella strains cause disease and trigger the abortion of developing embryos in livestock. The researchers have discovered a group of 24 genes that are linked to virulence by making comparisons of the newly available S19 genome sequence to previously sequenced genomes of two virulent strains of B. abortus. The paper "Genome sequence of Brucella abortus vaccine strain S19 compared to virulent strains yields candidate virulence genes" was published recently in PLoS One (May 2008, Volume 3, Issue 5, e2193).

Oswald Crasta, project director at VBI's Cyberinfrastructure Group and the corresponding author on the paper, remarked: "We have been able to leverage rapid sequencing of the S19 genome on the Roche GS-20 and GS-FLX platforms, and comparative genomics narrowed down the search for Brucella virulence factors to a small group of genes. Of particular interest are four genes that show consistently large sequence differences in S19 compared with two fully sequenced virulent strains." He added: "Further studies are underway to characterize the short list of protein differences that appear to be involved in cellular processes ranging from lipid transport and metabolism to tra
'/>"/>

Contact: Barry Whyte
whyte@vbi.vt.edu
540-231-1767
Virginia Tech
Source:Eurekalert

Page: 1 2

Related biology news :

1. Cold Spring Harbor Protocols features methods for analyzing genomes and plant cells
2. A common aquatic animals genome can capture foreign DNA
3. Scientists decipher fruit tree genome for the first time
4. Scientists discover small RNAs that regulate gene expression and protect the genome
5. First analysis of platypus genome may impact disease prevention
6. Duck-billed platypus genome sequence published
7. The FAQs about the human genome
8. Platypus genome decoded
9. First draft of transgenic papaya genome yields many fruits
10. Charting the epigenome
11. Tomato pathogen genome may offer clues about bacterial evolution

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/23/2009)... Iowa - The only swine vaccine available for the H...infected with the virus. The vaccination marks the...diagnosed with the pandemic flu., Iowa State Uni..., developed the vaccine this summer and has been s...a, Kansas and Illinois for several weeks., The l...
(Date:11/23/2009)...GN, Ill. Two new studies reveal in unprecedented ...ules to assemble new proteins and guide them towar...es used molecular dynamics flexible fitting (MDFF)...wo prominent molecular partners. , The first st...iences , concerns the intimate signaling between t...
(Date:11/23/2009)...ional Institute of General Medical Sciences (NIGMS..., is investing $42.3 million for grants in scienti...O)." NIH developed the GO grant program to stimula... provided by the American Recovery and Reinvestmen...ects that promise to have a significant impact on ...
Breaking Biology News(10 mins):Iowa State researcher produces, ships only H1N1 vaccine available for swine 2Computational microscope peers into the working ribosome 2Computational microscope peers into the working ribosome 3NIGMS invests in scientific Grand Opportunities with Recovery Act funds 2NIGMS invests in scientific Grand Opportunities with Recovery Act funds 3Platelet Rich Plasma 3A Does It Work 3F 58657 1Platelet Rich Plasma 3A Does It Work 3F 58657 2Platelet Rich Plasma 3A Does It Work 3F 58657 3Platelet Rich Plasma 3A Does It Work 3F 58657 4DST Systems Inc Announces Exchange Transaction Involving 4 125 25 Series A Convertible Senior Debentures 58653 1DST Systems Inc Announces Exchange Transaction Involving 4 125 25 Series A Convertible Senior Debentures 58653 2Medicago begins human clinical testing with its avian flu pandemic vaccine 14315 1Medicago begins human clinical testing with its avian flu pandemic vaccine 14315 2
...urned on to target and destroy foreign infectious ...n, it is just as important to turn the immune syst.... The fruit fly Drosophila has served as a good mo..., pointing to conserved pathways and mechanisms. R...more subtly regulated and produces a wider range o...
...ld at the University of Edinburgh, 3-6 September 2... fingers, faeces and flies: food and waterborne pa...s. , Hepatitis E virus (HEV), which can be fatal,...veloping countries but scientists in the Netherlan...e contracting the virus from pork. It is one of fe...
...els in coastal waters interfere with fish reproduc...cientist from The University of Texas at Austin Ma...seasonal low levels of oxygen, known as hypoxia, h...ghout the world over the past few decades, largely...ultural and industrial activities. Hypoxias long-t...
Other Biology News:Society for General Microbiology 161st Meeting, University of Edinburgh 2Low oxygen in coastal waters impairs fish reproduction 2
(Date:11/24/2009)... Health care employment grew by 29,000 jobs in Oc...consistent growth during the U.S. recession. Howev...ble, and health systems are coming closer to havin...st administrators. , (Voc...ntinued growing in October despite the shedding of...
(Date:11/24/2009)...Newswire-Asia/--ShanghaiBiolaxyannouncedthe,Chines...the,investigationalnewdrugapplication(IND)foritsor...lationtotreatdiabetes.ThisIND,approvalallowsBiolax...betesisadisordercharacteristicofhighbloodglucosean...sultinseveremicro-and,macro-vasculardiseases,losso...
(Date:11/24/2009)..., TORONTO,Nov.24/PRNewswire-FirstCall/-HamiltonT...eadingproviderofadvancedlasersystemsandinstruments...dayreportedoperationalandfinancialresultsforthethi...ts,-Revenuewas$1.46millioncomparedwith$1.43millio...with66.1percentinQ3,2008,-Netlossreducedto$148,000...
(Date:11/24/2009)...er24/PRNewswire/--HealthRoboticstodayannounced,tha...lected,investors.ThisrecentlyformedToronto-basedco...Inc.andwillmarket,install,andsupport,HealthRobotic...lutionaryproductofferingsi.v.STATION(TM),i.v.SOFT(...ovideassistanceonan"asneeded,basis"toitsstrategicp...
Breaking Biology Technology:The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 2The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 3The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 4Biolaxy Secures IND Approval for Oral Insulin 2Hamilton Thorne announces third quarter results 2Hamilton Thorne announces third quarter results 3Hamilton Thorne announces third quarter results 4Hamilton Thorne announces third quarter results 5Hamilton Thorne announces third quarter results 6Hamilton Thorne announces third quarter results 7Health Robotics Continues its Global Expansion With December 09 ASHP's Launch of Joint Venture in Canada 2
...AN DIEGO, Sept. 10 ADVENTRX Pharmaceuticals,Inc. ...elopment company,focused on commercializing propri...er and infectious diseases, announced today that i... Drug Administration (FDA) regarding its,proposed ...th for ANX-514,(docetaxel emulsion). The FDA has i...
...ompany to Hold a Conference Call Tomorrow (Tuesday...the Clinical Trial, Valley Cottage, NEW YORK, Sep...TLB ; LSE: XTL; TASE: XTL) today announced,the ini...e - a serotonin,and norepinephrine reuptake inhibi...thic pain. Bicifadine is being developed for the ...
...OUTH SAN FRANCISCO, Calif., Sept. 7 Monogram,Bios...t William D. Young, CEO,and Chairman, is scheduled...y Partners, G5: The Growth Conference on Monday, S...a.m. Pacific Time) at the St. Regis,Hotel in San F...oadcast or the subsequent archived,recording, log ...
Other Biology Technology:ADVENTRX Announces ANX-514 Clinical Development Plan Affirmed by the FDA 2ADVENTRX Announces ANX-514 Clinical Development Plan Affirmed by the FDA 3ADVENTRX Announces ANX-514 Clinical Development Plan Affirmed by the FDA 4XTL Biopharmaceuticals Initiates Phase IIb Clinical Trial of Bicifadine for the Treatment of Diabetic Neuropathic Pain 2XTL Biopharmaceuticals Initiates Phase IIb Clinical Trial of Bicifadine for the Treatment of Diabetic Neuropathic Pain 3XTL Biopharmaceuticals Initiates Phase IIb Clinical Trial of Bicifadine for the Treatment of Diabetic Neuropathic Pain 4XTL Biopharmaceuticals Initiates Phase IIb Clinical Trial of Bicifadine for the Treatment of Diabetic Neuropathic Pain 5XTL Biopharmaceuticals Initiates Phase IIb Clinical Trial of Bicifadine for the Treatment of Diabetic Neuropathic Pain 6XTL Biopharmaceuticals Initiates Phase IIb Clinical Trial of Bicifadine for the Treatment of Diabetic Neuropathic Pain 7Monogram Biosciences to Present at the ThinkEquity Partners' Fifth Annual Growth Conference 2
Human Antibody Array I Kit, RayBio L Series 507: RayBio Label-based from Raybiotech, Inc.
Mouse Anti-Human HVEM Cell Surface Staining Monoclonal Antibodies, Allophycocyanin Conjugated, 94801 from R&D Systems
... Osmometer for 10 L sample. Ideal for small volum...iatric, general adult, veterinary and experimental...selected values. Includes built-in printer, keypa...-keeping. Optional barcode scanner available. RS...
Rabbit Anti-Human UCP2 Polyclonal Antibody, Unconjugated from Proteintech Group, Inc.
Biology Products: